Votruba Michal
SEC insider (Form 3/4/5 filer). CIK 0001653967. Director at BioXcel Therapeutics, Inc. (BTAI). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 9, 2026. Located in NEW HAVEN, CT.
Companies Votruba Michal has filed insider reports for
- BioXcel Therapeutics, Inc. (BTAI): Director
Votruba Michal
CIK: 0001653967
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BTAI
BioXcel Therapeutics, Inc.
Director